Pharmaceutical composition comprising a cannabinoid Grant US-11806319-B2 United States of America 07 Nov 2023
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the… Grant US-11793770-B2 United States of America 24 Oct 2023
Use of cannabinoids in the treatment of epilepsy Grant US-11684598-B2 United States of America 27 Jun 2023
Use of cannabinoids in the treatment of Angelman syndrome Grant US-11679087-B2 United States of America 20 Jun 2023
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus Grant US-11406623-B2 United States of America 09 Aug 2022
Use of cannabidiol in the treatment of epilepsy Grant US-11400055-B2 United States of America 02 Aug 2022
Use of cannabinoids in the treatment of epilepsy Grant US-11357741-B2 United States of America 14 Jun 2022
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and… Grant US-11318109-B2 United States of America 03 May 2022
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus Grant US-11160795-B2 United States of America 02 Nov 2021
pH dependent release coated microparticle cannabinoid formulations Grant US-11160757-B1 United States of America 02 Nov 2021
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the… Grant US-11147776-B2 United States of America 19 Oct 2021
Use of cannabinoids in the treatment of epilepsy Grant US-11147783-B2 United States of America 19 Oct 2021
Use of cannabidiol in the treatment of epilepsy Grant US-11065209-B2 United States of America 20 Jul 2021
Use of cannabinoids in the treatment of multiple myeloma Grant US-11065227-B2 United States of America 20 Jul 2021
Use of cannabidiol in the treatment of epilepsy Grant US-10918608-B2 United States of America 16 Feb 2021
Use of cannabinoids in the treatment of epilepsy Grant US-10849860-B2 United States of America 01 Dec 2020
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy Grant US-10799467-B2 United States of America 13 Oct 2020
Use of cannabidiol in the treatment of epilepsy Grant US-10765643-B2 United States of America 08 Sep 2020
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and… Grant US-10729665-B2 United States of America 04 Aug 2020
Use of cannabinoids in the treatment of epilepsy Grant US-10709671-B2 United States of America 14 Jul 2020
Use of cannabinoids in the treatment of epilepsy Grant US-10603288-B2 United States of America 31 Mar 2020
Use of cannabinoids in the treatment of epilepsy Grant US-10583096-B2 United States of America 10 Mar 2020
Use of cannabinoids in the treatment of epilepsy Application US-10137095-B2 United States of America 27 Nov 2018
Use of cannabinoids in the treatment of epilepsy Grant US-10111840-B2 United States of America 30 Oct 2018
Use of cannabinoids in the treatment of epilepsy Application US-10092525-B2 United States of America 09 Oct 2018
Use of cannabinoids in the treatment of epilepsy Application US-9956184-B2 United States of America 01 May 2018
Use of cannabinoids in the treatment of epilepsy Grant US-9956186-B2 United States of America 01 May 2018
Use of cannabinoids in the treatment of epilepsy Application US-9956183-B2 United States of America 01 May 2018
Use of cannabinoids in the treatment of epilepsy Application US-9956185-B2 United States of America 01 May 2018
Use of cannabinoids in the treatment of epilepsy Application US-9949936-B2 United States of America 24 Apr 2018
Use of cannabinoids in the treatment of epilepsy Grant US-9949937-B2 United States of America 24 Apr 2018
Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy Grant US-9522123-B2 United States of America 20 Dec 2016